Inactivation of the p16 gene by hypermethylation and loss of heterozygosity in adenocarcinoma of the lung
Article first published online: 4 JUN 2004
DOI: 10.1111/j.1440-1827.2004.01655.x
Additional Information
How to Cite
Awaya, H., Takeshima, Y., Amatya, V. J., Furonaka, O., Tagawa, K., Kohno, N. and Inai, K. (2004), Inactivation of the p16 gene by hypermethylation and loss of heterozygosity in adenocarcinoma of the lung. Pathology International, 54: 486–489. doi: 10.1111/j.1440-1827.2004.01655.x
Publication History
- Issue published online: 4 JUN 2004
- Article first published online: 4 JUN 2004
- Received 12 December 2003. Accepted for publication 18 March 2004.
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , Alterations in p16 and p53 genes and chromosomal findings in patients with lung cancer: Fluorescence in situ hybridization and cytogenetic studies, Cancer Epidemiology, 2010, 34, 4, 472
- 2, , , , , , Chromosome 9 instability and alterations of p16 gene in squamous cell carcinoma of the lung and in adjacent normal bronchi: FISH and immunohistochemical study, Histopathology, 2008, 52, 4Direct Link:
- 3, , , , , , Role of DMP1 and its future in lung cancer diagnostics, Expert Review of Molecular Diagnostics, 2008, 8, 4, 435
- 4, , , , , , , Microsatellite and EGFR, HER2 and K-RAS Analyses in Sclerosing Hemangioma of the Lung, The American Journal of Surgical Pathology, 2007, 31, 10, 1512
- 5, , , , , , Papillary adenocarcinoma of the lung is a more advanced adenocarcinoma than bronchioloalveolar carcinoma that is composed of two distinct histological subtypes, Pathology International, 2005, 55, 10Direct Link:

1440-1827/asset/olbannerleft.gif?v=1&s=2be64b2770cee8eae71e05246f0144075d386209)
1440-1827/asset/olbannerright.gif?v=1&s=aaa7a938395d0764087845e803e88163fd32937c)
1440-1827/asset/cover.gif?v=1&s=6a782c691f698bd362f871858feb042904097b2e)